2015 leukemia & lymphoma society light the night walk

When Ferriter Scobbo shareholder Robert Granger was diagnosed with lymphoma at the end of 2010, the firm quickly rallied to support him in any small way we could. We called this effort “Grangers Changers.” 

Over the last 5 years, we have donated money in lieu of two firm Holiday Parties and gifts, started a change jar to collect small donations, held various fund raising functions and began a series of events. The events, called EpiCURE, combine guest speakers from government, sports and entertainment and about 20 guests to discuss issues of importance or interest. Attendees donate money in order to participate. Through all of our efforts, Ferriter Scobbo has raised a total of nearly $55,000.

Every cent we’ve raised, with the help of employees, management, friends, family and clients has been donated to the Massachusetts Chapter of the Leukemia & Lymphoma Society (LLS).

For the 5th year in a row, we have participated in LLS’s Light the Night Walk in Wakefield, MA.  For the second year in a row, we are proud to have teamed up with Constantino, Richards, Rizzo, a Wakefield accounting and consulting firm, to combine our fundraising forces.  For this year’s walk, we have raised more money than ever before, and donations keep coming! LLS awarded our team as the top Wakefield Light the Night group as well as most Corporate Fundraising Growth for 2015.

While Rob had been seemingly healthy for a couple of years, 2015 brought another fight against Lymphoma.  We are happy to report that Rob is slowly but surely beating this disease once again. We’re proud to continue to support him.

Thank you, to everyone, for their continued support of a world without blood cancer.  

The mission of The Leukemia & Lymphoma Society (LLS) is: Cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families.

LLS is the world's largest voluntary health agency dedicated to blood cancer. LLS funds lifesaving blood cancer research around the world and provides free information and support services. More than 75% of LLS funds go to research, patient services, public health education and professional education. LLS key priorities will ensure that: The Leukemia & Lymphoma Society helps blood cancer patients live better, longer lives.